Leave Your Message
FDA 510(k) for Contact Lenses: What a Brand Owner Actually Has to Do
Blog

FDA 510(k) for Contact Lenses: What a Brand Owner Actually Has to Do

2026-10-12

FDA 510(k) for Contact Lenses: What a Brand Owner Actually Has to Do

US Market Access510(k) and Registration
Key Takeaways
  • Most brand owners never submit a 510(k). The clearance belongs to the manufacturer and covers the device. What the brand owner owns is a different set of obligations that most first-time sellers discover late.
  • Classification comes first. Under 21 CFR 886.5925, a soft contact lens isClass II if intended for daily wear only and Class III if intended for extended wear. Class III requires a PMA, not a 510(k).
  • A decorative or zero-power lens is not exempt. The absence of a corrective function does not change the classification.
  • Two activities trigger your own registration and listing: developing the specification for a device made by someone else, and repackaging or relabelling a device. Putting your brand on the box is relabelling.
  • A pure wholesale distributor who does not manufacture, repackage or relabel is excluded from registration and listing under 21 CFR 807.20(c).
  • Since 2 February 2026 the FDA's quality system rule (QMSR) incorporates ISO 13485:2016 by reference, which makes an ISO 13485-certified factory a materially stronger starting point than it was a year ago.

The Short Answer: Most Brand Owners Do Not Submit a 510(k)

A brand owner entering the United States market for the first time usually asks the same question: how do I get FDA approval for my contact lenses? The question contains two assumptions, and both are wrong in ways that matter.

The first is that the brand needs its own clearance. In the great majority of private label and OEM arrangements it does not. The 510(k) belongs to whoever submitted it — normally the manufacturer — and it covers the device rather than the brand name printed on the box. A brand selling a lens that is identical to a cleared device is selling a cleared device.

The second assumption is that the 510(k) is the whole of the regulatory obligation. It is one part of it, and for a brand owner it is usually the part they do not have to do. What they do have to do sits elsewhere: establishment registration, device listing, labelling, and unique device identification. These are the obligations that catch first-time sellers out, because they are administrative, they are annual, and nobody advertises them.

The purpose of this guide is to separate the two. Sections below cover what the clearance actually is, which class applies to your lens, what is genuinely the brand owner's responsibility, and what to verify about a factory before relying on any of it.

This is a practical orientation for commercial planning, not regulatory or legal advice. Classification, clearance scope and registration obligations depend on the specific device and the specific activities a company performs, and should be confirmed with a qualified regulatory professional or directly with the FDA before any product is placed on the US market.

image.png

First, Which Class Is Your Lens?

Everything downstream depends on this, and it is determined by the intended wearing schedule rather than by the material or the design.

The controlling regulation is 21 CFR 886.5925, which defines a soft (hydrophilic) contact lens and then splits it in two:

  • Class II if the device is intended for daily wear only.
  • Class III if the device is intended for extended wear.

That single sentence is the most consequential line in the whole framework. Class II devices reach the market through a 510(k) premarket notification, a comparatively manageable submission. Class III devices require a Premarket Approval (PMA) — a substantially heavier process with clinical evidence requirements, and the regulation notes that an approval under section 515 has been required for extended-wear lenses since 28 May 1976.

For most private label ranges this means daily wear, Class II, and the 510(k) route. But the distinction has to be settled deliberately rather than assumed, because the words on the packaging and in the marketing copy are what establish the intended wearing schedule. A range described as suitable for overnight or continuous wear is not a Class II product, whatever the factory's existing clearance covers.

Question Daily wear Extended wear
FDA class Class II Class III
Route to market 510(k) premarket notification Premarket Approval (PMA)
Typical product code LPL — lenses, soft contact, daily wear Different code and a PMA-based pathway
Evidence burden Substantial equivalence to a predicate device Clinical evidence supporting the approval
What it means for a brand owner Usually satisfied by the manufacturer's existing clearance Rarely available as a private label route; requires a manufacturer already holding a PMA

Classification follows the intended wearing schedule stated on the labelling and in the marketing material, not the physical characteristics of the lens.

A decorative lens is not an exempt lens

One misunderstanding recurs often enough to state separately. A coloured, cosmetic or zero-power contact lens is still a contact lens under 21 CFR 886.5925, because the definition turns on the device being worn against the cornea, not on whether it corrects vision. There is no cosmetic exemption and no non-prescription category.

The practical consequence is that a Halloween or fashion range sold into the United States carries exactly the same regulatory burden as a vision-correction range. Our Halloween safety guide covers what that means in the seasonal context, and coloured contact lens safety explains why the pigment construction matters independently of the regulatory position.

What the 510(k) Actually Is

A 510(k) is a premarket notification, not an approval. This is not pedantry — the vocabulary reflects the legal mechanism. The submitter demonstrates that the new device is substantially equivalent to a legally marketed predicate device, and the FDA issues a clearance permitting marketing. Nothing is being approved on its own merits.

For a daily-wear soft contact lens the mechanics are well established. The device falls under regulation 886.5925, is assigned product code LPL, is classified as Class 2, and requires a 510(k). The FDA's classification record for LPL also notes two details worth knowing:

  • The device is not GMP exempt. Quality system requirements apply in full, which is where the QMSR discussion later in this article becomes relevant.
  • It is eligible for the 510(k) Third Party Review Program. An accredited third party can review the submission, which in practice can shorten the timeline considerably compared with a full FDA review.

The testing a factory has to be able to evidence

The FDA recognises a set of consensus standards for the LPL product code, and these are the backbone of what a submission has to demonstrate. They are worth knowing because they tell a buyer exactly which test reports to request from a factory.

The list includes the ISO 18369 series covering vocabulary and labelling conventions, tolerances, measurement methods and physicochemical properties of lens materials; ISO 11978 on contact lens labelling; ISO 9394 on ocular biocompatibility; ISO 11980 on clinical investigation guidance; ISO 11981 and ISO 11986 on interactions between lenses and care products; ISO 18259 on antimicrobial challenge testing in lens cases; ISO 18189 on cytotoxicity in combination with care solutions; ANSI Z80.20 on terminology, tolerances and measurements; and ASTM D882 on tensile properties of thin plastic sheeting.

A factory that cannot produce current test reports traceable to these standards is either relying on a clearance it cannot support or has not been through the exercise. Our compliance vetting checklist covers how to request and read them.

The Three Things That Are Actually Yours

If the clearance is the factory's, these are the obligations that attach to the brand owner. Two of them are triggered by ordinary private label activity, which is the part most sellers do not expect.

1. Establishment registration and device listing

The rule is 21 CFR 807.20. It applies to any person engaged in the manufacture, preparation, propagation, compounding, assembly or processing of a device — and it then spells out, in paragraph (a), a list of activities that count. Two of them describe private label work precisely:

  • 807.20(a)(1) — any person who "initiates or develops specifications for a device that is to be manufactured by a second party". A brand that commissions a design, or specifies the material, parameters and packaging, is a specification developer.
  • 807.20(a)(3) — any person who "repackages or relabels a device". Putting your own brand on a finished product is relabelling.

Both of those are ordinary private label activities. A brand that commissions a design and applies its own label has done both.

The counterweight is 807.20(c), which excludes a person who "acts as a wholesale distributor … and who does not manufacture, repackage, process, or relabel a device". That is the genuine reseller: someone who buys finished, branded product and passes it along unchanged. This is a narrower category than most people assume, and it is the distinction that decides whether registration is required.

What you actually do FDA role Register and list?
You specify the design, material, parameters or packaging; a factory manufactures it Specification developer — 807.20(a)(1) Yes
You apply your own brand, artwork or label to a finished device Repackager or relabeller — 807.20(a)(3) Yes
You buy finished product carrying the manufacturer's brand and resell it unchanged Wholesale distributor — 807.20(c) No

Private label sits in the first two rows, not the third. Registration is annual and carries a fee, and the listing must reference a clearance for the device.

Registration and listing are handled through the FDA's electronic system and are annual, with the update window running from 1 October to 31 December each year. A registration that lapses takes the ability to import with it, because the FDA's rule for foreign establishments is explicit that no device may be imported or offered for import unless it is the subject of a device listing and is manufactured at a registered establishment.

2. Labelling

Labelling obligations sit alongside the clearance and follow the device, not the clearance holder. The general requirements are in 21 CFR 801, and ISO 11978 is the recognised consensus standard for contact lens labelling specifically.

For a private label range this is where the identity question becomes concrete. The label names a manufacturer, and that name has regulatory weight: it determines who the FDA contacts, who answers for the device, and who is inspected. A brand that has commissioned the design and relabelled the product cannot simply leave its own name off and point to the factory, and it should not assume the factory will accept being named in a role it does not hold.

In practice the label has to be agreed rather than assumed, and it has to satisfy the requirements of every market the range is sold into. Those requirements diverge substantially — our country-by-country comparison sets out how far, and the labelling section of our private label manufacturing overview covers the artwork workflow that produces it.

3. Unique Device Identification

Contact lenses are subject to the FDA's Unique Device Identification system, which requires a UDI on the label and in a publicly accessible database. For a private label range this is a labelling and data-entry task rather than a technical one, but it is not optional and it has to be complete before the product is commercially distributed.

It is also one of the items most often left until after artwork is approved, at which point it forces a reprint. Building the UDI into the artwork brief from the start costs nothing; adding it afterwards costs a print run.

What to Verify About the Factory

Everything above rests on the manufacturer's clearance being real, current, and wide enough to cover the specific device being ordered. That is a verification exercise rather than a trust exercise, and it takes four documents.

What to request What it establishes What to check
The 510(k) clearance letter and its summary The device described is cleared for US marketing, and under which product code That the device in the summary matches what you are ordering — material, wearing schedule, parameters — rather than a related product
Current establishment registration The manufacturing site is registered for the current annual cycle That the registration covers the actual site of manufacture, not a parent entity or a different facility
US Agent designation A US agent is appointed, as required of foreign establishments That the agent is current, since changes must be reported to the FDA within 10 business days
ISO 13485 certificate and quality system evidence The quality system position, now directly relevant to the FDA's QMSR Scope, issuing body, expiry, and whether the certified scope covers the product and site

The 510(k) is device-specific, not company-specific. A factory holding a clearance does not thereby hold a clearance for every lens it can produce.

The last line is the one that causes the most trouble. A clearance covers the device as described in the submission. Change the material, the wearing schedule or the fundamental construction and it is no longer the cleared device, whatever the factory's certificate says. Constar holds FDA 510(k) clearance alongside CE 0197 marking and ISO 13485 certification, with national registrations in Australia, Saudi Arabia, Indonesia, Thailand and Vietnam — the portfolio is set out on markets we serve — and applicable scope is confirmed per project rather than inferred from the existence of a certificate. The 12-point manufacturer scorecard puts each of these claims against a document you can request.

Foreign Establishments and the US Agent

Because most private label contact lenses are manufactured outside the United States, one further requirement applies to the factory rather than to the brand. Under 21 CFR 807.40, a foreign establishment engaged in manufacturing a device imported into the United States must register and list, and must submit the name, address and telephone number of its United States agent as part of its registration information.

The rule is specific about what the agent is for. Each foreign establishment designates only one US agent, who must reside or maintain a place of business in the United States. The agent assists the FDA in communicating with the establishment, responds to questions about the imported products, and assists in scheduling inspections. Critically, the regulation provides that where the FDA cannot reach the foreign establishment directly or expeditiously, information or documents provided to the US agent are treated as having been provided to the establishment.

That last provision is why the agent's identity is worth knowing rather than merely checking that one exists. For a brand owner it is also a practical point of contact: if something goes wrong with an imported shipment, the agent is the party the FDA will speak to first.

Why the QMSR Change Matters to Buyers

The most significant recent change in US device regulation took effect on 2 February 2026, and it has a direct bearing on how a buyer should assess a factory.

The FDA's Quality Management System Regulation (QMSR) amended the device current good manufacturing practice requirements of 21 CFR Part 820 by incorporating ISO 13485:2016 by reference, along with clause 3 of ISO 9000:2015. In the FDA's own framing, this harmonises the US regulatory framework with those used by other authorities. Where a clause of ISO 13485 conflicts with the Federal Food, Drug, and Cosmetic Act or its implementing regulations, the Act and its regulations control.

Three practical consequences follow.

First, an ISO 13485 certificate now carries more weight in the US context than it did before. It is no longer merely an internationally recognised credential that sits alongside a separate US quality system requirement; ISO 13485 is the framework the FDA has incorporated. A factory certified to it is working to the same quality management standard the US rule now references.

Second, risk management is now explicitly required as part of the framework, because ISO 13485 requires it. That is a substantive change in what a compliant quality system has to contain, not a change of terminology.

Third, inspection practice changed with it. The FDA stopped using the Quality System Inspection Technique on 2 February 2026 and moved to a new inspection process under compliance programme 7382.850. The device is not GMP exempt, so a contact lens manufacturer is squarely within scope.

For a buyer the takeaway is narrow and useful: the question to ask a factory has changed from "are you FDA registered?" to "which quality system standard is your system built to, and can you evidence it?" A supplier that can produce a current ISO 13485 certificate with the right scope is answering the QMSR question at the same time.

The Sequence, in Order

  1. Confirm the wearing schedule. Daily wear is Class II and the 510(k) route; extended wear is Class III and requires a PMA. Settle this before anything else, because it determines whether the project is feasible at all.
  2. Confirm the device is covered by an existing clearance. Request the clearance letter and its summary, and check that the device described matches what you intend to order. If it does not, the route changes.
  3. Determine which FDA role your activities create. Commissioning the specification and applying your own label are two separate triggers under 807.20(a). Confirm whether either applies before assuming you are outside the registration requirement.
  4. Register and list if required, and budget for the annual cycle. Registration runs on the October to December window and carries a fee. Diarise it rather than discovering the lapse.
  5. Settle the label, including the UDI, before artwork is approved. The label names the manufacturer of record and must satisfy every destination market. Changing it after the print run is the most expensive way to fix a regulatory detail.
  6. Verify the factory's registration, US agent and quality system scope in writing. Each of these is a document, not an assurance. Our comparison of OEM, ODM and private label explains how the design-ownership model affects which of these obligations lands on you, and the cost driver breakdown explains where regulatory scope sits in the overall programme cost.

Frequently Asked Questions

Clearance and classification

Do I need my own FDA 510(k) to sell private label contact lenses?

In most private label arrangements, no. The 510(k) belongs to whoever submitted it, normally the manufacturer, and it covers the device rather than the brand on the box. A brand selling a lens identical to a cleared device is selling a cleared device. If the device is modified — different material, different wearing schedule — it is no longer the cleared device and the position changes.

Are coloured or cosmetic contact lenses exempt from FDA requirements?

No. Under 21 CFR 886.5925 the definition turns on the device being worn against the cornea, not on whether it corrects vision. A coloured, theatrical or zero-power lens is a contact lens and carries the same classification and clearance requirements as a vision-correction lens. There is no cosmetic exemption and no non-prescription category for contact lenses in the United States.

What is the difference between 510(k) clearance and FDA approval?

A 510(k) is a premarket notification, and the FDA issues a clearance rather than an approval. The submitter demonstrates that the device is substantially equivalent to a legally marketed predicate device. Premarket Approval, or PMA, is a different and much heavier process reserved for Class III devices. Extended-wear soft contact lenses fall into that category, which is why they cannot be brought to market on a 510(k).

Registration and obligations

Does a private label brand have to register with the FDA?

It depends on what the brand actually does. Under 21 CFR 807.20, registration and listing apply to anyone who initiates or develops specifications for a device manufactured by a second party, and to anyone who repackages or relabels a device. Applying your own brand is relabelling. A wholesale distributor who does not manufacture, repackage or relabel is excluded by 807.20(c), but that is a narrower category than it sounds.

How often does FDA establishment registration need to be renewed?

Annually. The update window runs from 1 October to 31 December each year, and a registration fee applies. Allowing it to lapse matters more than it might appear: the FDA's rule for foreign establishments provides that no device may be imported or offered for import unless it is the subject of a device listing and was manufactured at a registered establishment.

What is a US Agent and does my supplier need one?

Under 21 CFR 807.40, a foreign establishment manufacturing devices imported into the United States must register, list, and submit the name, address and phone number of a United States agent. Only one agent may be designated, and the agent must maintain a place of business in the United States. Documents the FDA provides to the agent are treated as provided to the establishment, so the agent's identity is worth knowing.

Working with a manufacturer

How do I check that a manufacturer's 510(k) actually covers my product?

Request the clearance letter and its summary, then compare the device described there against what you intend to order — material, wearing schedule, parameters and construction. A clearance is device-specific rather than company-specific, so a factory holding one clearance has not thereby cleared every lens it can produce. Where the description does not match your product, ask what the correct route is rather than assuming coverage.

What changed with the FDA quality system rules in 2026?

The Quality Management System Regulation took effect on 2 February 2026, amending 21 CFR Part 820 to incorporate ISO 13485:2016 by reference and harmonising the US framework with international practice. Risk management is now explicitly required, and the FDA moved to a new inspection process. For buyers, an ISO 13485 certificate with the correct scope now answers more of the US quality system question than it did previously.

Related

For how regulatory scope sits within the overall programme budget, see How Much Does Private Label Contact Lens Manufacturing Cost? For the design-ownership decision that determines which of these obligations falls on the brand, see OEM vs ODM vs Private Label Contact Lenses. For the certification documents to request, see How to Vet a Contact Lens Manufacturer.

Also in this series

Contact Lens Safety Standards by Country — how requirements diverge between the US, EU, UK and Asia. FDA Contact Lens Enforcement in 2026 — what the agency is currently acting on. Private Label Contact Lens Manufacturer — the packaging and branding layers alongside the regulatory work. Base Curve and Diameter Explained — the parameters that have to match the cleared device.